We are live on ! Find out more
PASG icon

Passage Bio
PASG

67 hedge funds and large institutions have $51.5M invested in Passage Bio in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more capital invested

Capital invested by funds: $38.1M → $51.5M (+$13.4M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.19% less ownership

Funds ownership: 3.62% → 3.43% (-0.19%)

11% less funds holding

Funds holding: 75 → 67 (-8)

40% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 25

53% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 15

Holders
67
Holders Change
-8
Holders Change %
-10.67%
% of All Funds
1.08%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
7
Increased
15
Reduced
25
Closed
15
Calls
$26K
Puts
–
Net Calls
+$26K
Net Calls Change
-$36K

Top Buyers

1
LCM
Lynx1 Capital Management
Puerto Rico
+$761K
2
NM
Newtyn Management
New York
+$618K
3
EAM
Erste Asset Management
Austria
+$492K
4
BCM
Bridgeway Capital Management
Texas
+$412K
5
B
Bailard
California
+$198K

Top Sellers

1
DTC
Deep Track Capital
Connecticut
-$1.8M
2
Morgan Stanley
Morgan Stanley
New York
-$587K
3
WP
Woodline Partners
California
-$530K
4
BlackRock
BlackRock
New York
-$278K
5
Marshall Wace
Marshall Wace
United Kingdom
-$242K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$12.3M – – –
VVM
2
Versant Venture Management
California
$6.84M – – –
FLSM
3
Frazier Life Sciences Management
California
$5.18M – – –
LCM
4
Lynx1 Capital Management
Puerto Rico
$4.63M +$761K +30,175 +22%
NLVP
5
New Leaf Venture Partners
New York
$3.45M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$2.78M +$1.03K +41 +0%
EAM
7
Erste Asset Management
Austria
$2.15M +$492K +19,500 +33%
Renaissance Technologies
8
Renaissance Technologies
New York
$1.64M -$88.6K -3,512 -6%
BlackRock
9
BlackRock
New York
$1.55M -$278K -11,012 -16%
RCMNY
10
Rubric Capital Management (New York)
New York
$1.13M – – –
NM
11
Newtyn Management
New York
$1.09M +$618K +24,500 +163%
JP Morgan Chase
12
JP Morgan Chase
New York
$813K -$2.8K -111 -0.4%
Acadian Asset Management
13
Acadian Asset Management
Massachusetts
$798K +$102K +4,062 +16%
Millennium Management
14
Millennium Management
New York
$676K -$103K -4,087 -14%
BCM
15
Bridgeway Capital Management
Texas
$676K +$412K +16,325 +200%
Two Sigma Advisers
16
Two Sigma Advisers
New York
$607K -$87.2K -3,455 -14%
WMSA
17
Weiss Multi-Strategy Advisers
New York
$507K – – –
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$501K -$20.7K -819 -4%
Two Sigma Investments
19
Two Sigma Investments
New York
$489K -$39.6K -1,570 -8%
BCM
20
BML Capital Management
Indiana
$466K +$426K +16,873 New
Geode Capital Management
21
Geode Capital Management
Massachusetts
$458K -$26K -1,031 -6%
OMC
22
Oasis Management Company
Cayman Islands
$331K – – –
NYLIM
23
New York Life Investment Management
New York
$253K +$26K +1,031 +13%
B
24
Bailard
California
$217K +$198K +7,845 New
State Street
25
State Street
Massachusetts
$171K – – –
1
2 3 4

PASG Hedge Fund Activity: Q4 2022 in Review

67 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Passage Bio (PASG) for Q4 2022, worth a combined $51.5M — up 35% from $38.1M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of PASG and 7 opened new positions — a net loss of 8 holders — while 25 trimmed existing stakes and 15 added.

The largest buyer was Lynx1 Capital Management, adding an estimated $761K. The largest seller was Deep Track Capital, exiting entirely with an estimated $1.8M sold.

  • 67 institutional investors held Passage Bio (PASG) as of Q4 2022, down from 75 in Q3 2022.
  • Funds reported $51.5M of Passage Bio stock for Q4 2022, up 35% quarter-over-quarter.
  • 7 funds opened new Passage Bio positions in Q4 2022 and 15 closed out, a net change of -8 holders.
  • The largest Passage Bio buyer in Q4 2022 was Lynx1 Capital Management, an estimated $761K added.
  • The largest Passage Bio seller in Q4 2022 was Deep Track Capital, an estimated $1.8M sold.

Based on aggregated 13F filings for Q4 2022.